Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

NCT02669849 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Spinal Cord Injury

Interventions

DRUG: VX-210
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated